HER-2-negative breast cancer limitations and next-generation sequencing technology promises (Journal article)

Baltogiannis, G./ Katsios, C./ Zografos, G. C./ Roukos, D. H.

Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Breast Neoplasms/drug therapy/*genetics/mortality/pathology,Disease-Free Survival,Female,Genetic Predisposition to Disease,Humans,Prognosis,Receptor, erbB-2/*genetics,Receptors, CXCR4/genetics,Sequence Analysis, DNA/methods,Tumor Markers, Biological/*genetics
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/21258
ISSN: 1534-4681
Link: http://www.ncbi.nlm.nih.gov/pubmed/20198443
http://www.springerlink.com/content/32831h8410253658/fulltext.pdf
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Baltogiannis-2010-HER-2-negative breas.pdf126.69 kBAdobe PDFView/Open    Request a copy


 Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/21258
  This item is a favorite for 0 people.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.